Supreme Court Temporarily Allows Baby-Killing Drug for Mail Orders, Overriding State Laws
The Supreme Court has temporarily allowed the mailing of mifepristone, a drug used in medication abortions, while legal challenges from Louisiana and other states continue. The decision overrides state laws that restrict access to the drug and reinstates a policy permitting mail-order distribution. The temporary order, issued by Justice Samuel Alito, is set to last through May 11, 2026.
- ▪The Supreme Court temporarily permitted the mailing of mifepristone despite state laws banning or restricting its use.
- ▪Justice Samuel Alito issued the temporary order allowing continued mail-order access to the abortion drug.
- ▪The order remains in effect through May 11, 2026, while litigation from multiple states proceeds.
- ▪The National Association of Pro-life Nurses opposed the FDA's removal of in-person visit requirements for mifepristone, citing safety risks.
- ▪Critics argue that mail-order access to abortion pills increases risks for women, including those with ectopic pregnancies, and enables abuse by traffickers.
Opening excerpt (first ~120 words) tap to expand
Supreme Court Temporarily Allows Baby-Killing Drug for Mail Orders, Overriding State Laws Catherine Salgado | 12:18 PM on May 04, 2026 AP Photo/Jose Luis Magana Tragically, the Supreme Court has temporarily reversed a lower court ruling blocking mail orders of the deadly abortion drug mifepristone while multiple states try to enforce their laws against the drug. Advertisement googletag.cmd.push(function () { googletag.display("div-gpt-300x250_3"); //googletag.pubads().refresh([gptAdSlot["div-gpt-300x250_3"]]) }); This is certainly a blow not only against the right to life, which the Founding Fathers affirmed in our Declaration of Independence (and arguably of the 14th Amendment right to life unless deprived by due process), but against states’ rights.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at PJ Media.
Discussion
0 commentsMore from PJ Media
